Charles River

The rise and rise of CRO employment levels

15-Sep-2009 By Nick Taylor

CRO employment levels have soared in recent years, almost doubling at some companies, and this rise, and recent dip, is presented and discussed by Outsourcing-Pharma using an interactive animated chart.

Charles River opens preclinical centre in Shanghai

16-Oct-2008 By Gareth Macdonald

Charles River Laboratories has opened a new preclinical development facility in Shanghai, China which, the firm says, will act as a centre of excellence and help strengthen its position in the global outsourcing market.

Charles River expands Discovery Services

17-Sep-2008 By Dr Matt Wilkinson

Charles River Laboratories has agreed to buy US-based drug discovery imaging expert Molecular Imaging Research, Inc. (MIR) for approximately $12.5m (€8.8m) in cash.

Research business lifts Charles River in 2Q

11-Aug-2008 By Phil Taylor

Charles River Laboratories saw its operating income advance 16 per cent to $77m in the second quarter on strong demand for its research services division, and also announced a $53m deal to buy a German contract service organisation.

Charles River's mini-lab 'out of this world'

12-Apr-2007 By Dr Matt Wilkinson

Charles River Laboratories' portable endotoxin testing system, the
Endosafe PTS, has been successfully used to detect bacteria on the
International Space Station (ISS).

Charles River wants a piece of the Chinese market pie

27-Mar-2007 By Emilie Reymond

Contract research organisation (CRO) Charles River Laboratories has
announced it will establish a presence in China by signing a joint
venture deal with Shanghai BioExplorer, a Chinese preclinical
services provider.

Charles River knuckles down on preclinical biz

24-Jan-2007 By Emilie Reymond

Charles River Laboratories confirmed it is persevering in its
intention to focus on its preclinical and Phase I businesses while
abandoning its late stage development services, during a conference
earlier this month.

Kendle feeds on Charles River restructure

23-May-2006 By Kirsty Barnes

Kendle has seized a chance to expand and diversify its business,
snapping up the Phase II-IV Clinical Services unit of Charles River
Laboratories after it decided to get out of this area of clinical
trial services and focus instead...

Charles River 1Q reflects outsourcing trend

04-May-2005 By Wai Lang Chu

Charles River Laboratories saw a double-digit boost in fiscal first
quarter revenues reflecting a jump in operating earnings, helped by
its acquisition of Inveresk Research Group and the emerging trend
in outsourcing preclinical services.